Measurement Use vial concentration math and U-100 insulin syringe units for injectable format
Minimum two to four weeks often required before judging effectiveness for chronic conditions, with some injuries needing six or more weeks to show meaningful response
Directed human clinical trials are necessary to validate BPC-157's efficacy in musculoskeletal injury, gastrointestinal, and vascular disorders that show promise in preclinical models
Product Overview BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice
Extensive preclinical research shows TB-500 stimulates angiogenesis, promotes wound healing, reduces inflammation, inhibits apoptosis, and enhances tissue perfusion in models of muscle, tendon, ligament, and dermal injury
BPC-157 promotes tissue repair through enhanced blood vessel formation and reduced inflammatory markers, while cryotherapy provides immediate pain relief and decreases acute inflammation